Abstract

4070Background: TGFβ signaling is associated with HCC progression. Here we report the results of a cohort of patients with HCC and normal serum AFP treated with galunisertib as part of a larger pha...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract C261: Pharmacokinetics (PK) and pharmacodynamics (PD) of the oral transforming growth factor-beta (TGF-β) receptor I kinase inhibitor LY2157299 monohydrate (LY) in hepatocellular carcinoma (HCC) compared to glioma patients.
Jean-Yves Douillard ... Gianluigi Giannelli
Molecular Cancer Therapeutics | VOL. 12
Jean-Yves Douillard, et. al.Jean-Yves Douillard ... Gianluigi Giannelli
01 Nov 2013
A phase 2 study of a novel transforming growth factor-beta (TGF-β1) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC).
Karim A Benhadji ... Mary Frances Mulcahy
Journal of Clinical Oncology | VOL. 32
Karim A Benhadji, et. al.Karim A Benhadji ... Mary Frances Mulcahy
20 Jan 2014
Prognostic Significance of Simultaneous Measurement of Three Tumor Markers in Patients With Hepatocellular Carcinoma
Akihiro Yamaguchi ... Takashi Kumada
Clinical Gastroenterology and Hepatology | VOL. 4
Akihiro Yamaguchi, et. al.Akihiro Yamaguchi ... Takashi Kumada
01 Jan 2006
Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein
Seonggyun Han ... Seyoun Byun
BMC Medical Genomics | VOL. 13
Seonggyun Han, et. al.Seonggyun Han ... Seyoun Byun
01 Dec 2020
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers